LDR Receives Approvable Letter From FDA for Mobi-C Device

LDR has received an approvable letter from the FDA for its Mobi-C Cervical Disc.

Advertisement

Mobi-C is a metal and polyethylene mobile bearing prosthesis specifically designed as a low-profile cervical intervertebral disc replacement for both one and two level applications.

The company has expressed confidence in completing the remaining requirements in the full approval process and it anticipates commercial U.S. availability of Mobi-C in 2013.

More Articles on Orthopedic Devices:

Alphatec Spine 3Q Revenue Drops 1.6%

Amedica Names Jay Moyes to Board of Directors

Globus Medical 3Q Worldwide Sales Reach $94.8M, Up 12.5%

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.